Month: June 2020

The Trump administration picked out five companies it believes are most likely to produce 2020’s holy grail – a vaccine for the coronavirus. Unfortunately, Novavax (NVAX) was not on the list.Although the White House didn’t disclose what lay behind the choices, 5-star B.Riley FBR analyst Mayank Mamtani provided some possible explanations.3 of the choices already have clinical studies in various degrees of progress (Moderna, AstraZeneca/Oxford University and Pfizer/BioNTech), whilst Novavax only began enrollment late last month. This implies to Mamtani that “speed to market entry” could be a major factor in the decision-making process.Whilst “risk diversification and cost sharing,” and …read more […]

Remaining afloat has become more than just a scientific feat for the beleaguered cruise industry. It has, figuratively, been the first port of call for cruise line operators during the pandemic. The global grounding of the entire industry has raised questions whether cruise lines can make it through the COVID-19 storm.For Tigress Financial’s Ivan Feinseth, one company to certainly sail through to the other side will be Norwegian Cruise Line (NCLH). The 5-star analyst anticipates NCLH will “overcome COVID-19 pandemic headwinds and emerge a stronger, and even better-positioned industry leader.” Feinseth has a list of reasons to back up his …read more […]

In just a couple of weeks, Aurora Cannabis (ACB) has surged back to a rich valuation. The most recently news has the Canadian cannabis company entering the U.S. CBD space via an acquisition set to close in June.The stock originally surged over 36% on the news leading to an increase in the stock value by over $500 million. Aurora Cannabis has cooled off some following the weak quarter from Canopy Growth, but investors need to realize that the CBD space in the U.S. is still held back by FDA restrictions. Wall Street is not convinced that Aurora’s reward is worth …read more […]

Despite having a cautious view on the iPhone, Credit Suisse raised the price target for Apple, crediting the growth from the App Store. Credit Suisse maintained the Neutral ratings however because the stock is close to its all time highs, claiming that it advises investors to wait for a lower point of entry.
…read more […]

After nailing the market’s recovery, Fundstrat’s Tom Lee is predicting hard hit stocks can carry the S&P 500 to new highs. …read more […]